Provided by Tiger Fintech (Singapore) Pte. Ltd.

crane

186.61
-0.0600-0.03%
Post-market: 187.000.3900+0.21%16:29 EDT
Volume:409.98K
Turnover:76.61M
Market Cap:10.73B
PE:32.38
High:188.95
Open:186.62
Low:185.32
Close:186.67
Loading ...

Press Release: ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

Dow Jones
·
14 May

Press Release: SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
14 May

Press Release: CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

Dow Jones
·
13 May

Crane Is Maintained at Hold by Stifel

Dow Jones
·
01 May

Deutsche Bank Lifts Price Target on Crane to $187 From $186, Keeps Buy Rating

MT Newswires Live
·
30 Apr

CERo Therapeutics Holdings, Inc. Announces TriStar Centennial Medical Center as a Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia

GlobeNewswire
·
30 Apr

Crane Co (CR) Q1 2025 Earnings Call Highlights: Strong Core Sales Growth and Record Backlog ...

GuruFocus.com
·
30 Apr

Q1 2025 Crane Co Earnings Call

Thomson Reuters StreetEvents
·
30 Apr

Crane Company Shares Rise After Upgrade From UBS

MT Newswires Live
·
30 Apr

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

Benzinga
·
29 Apr

Crane Co : UBS Raises to Buy From Neutral; Raises Target Price to $190 From $157

THOMSON REUTERS
·
29 Apr

UBS Upgrades Crane to Buy From Neutral

MT Newswires Live
·
29 Apr

Crane Raised to Buy From Neutral by UBS

Dow Jones
·
29 Apr

BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma

ACCESS Newswire
·
29 Apr

Crane 1Q Profit Soars on Higher Revenue

Dow Jones
·
29 Apr

Crane Co reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
29 Apr

Crane Holdings Q1 Adj. EPS $1.39 Beats $1.31 Estimate, Sales $557.60M Beat $547.96M Estimate

Benzinga
·
29 Apr

BRIEF-Crane Company Q1 Sales USD 557.6 Million Vs. IBES Estimate USD 548 Million

Reuters
·
29 Apr

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

GlobeNewswire
·
29 Apr

CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why

Benzinga
·
28 Apr